600721
vs
S
Shanghai Composite
600721
Over the past 12 months, Xinjiang Bai Hua Cun Pharma Tech Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +49% compared to the Shanghai Composite's +27% growth.
Stocks Performance
600721 vs Shanghai Composite
Performance Gap
600721 vs Shanghai Composite
Performance By Year
600721 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.